You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

4884 Results
There are 2 objectives for creating a regimen taxonomy. The first is to establish standard terms for regimen monographs to improve consistency,...
The New Drug Funding Program (NDFP) and pays for many newer, and often very expensive, injectable cancer drugs administered in hospitals and cancer...
The Evidence Building Program (EBP) helps to strengthen the process for making drug funding decisions in Ontario.
Recognizing the challenge and opportunity of take-home cancer medications, Cancer Care Ontario hosted a policy planning and consultation session in...
The Ontario Steering Committee for Cancer Drugs (OSCCD) was created in 2013 to enhance and support the administration of Ontario's cancer drug...
We’ve compiled the answers to many commonly asked questions about cancer drug costs and funding in Ontario.
The Drug Formulary documents are evidence-informed. Healthcare providers can find drug monographs, regimens, side effect and symptom management...

Pages